CARDIOVASCULAR DISEASES
Clinical trials for CARDIOVASCULAR DISEASES explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR DISEASES trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug tested to fight COVID-19 complications
Disease control TerminatedThis study tested a drug called CardiolRx in 90 hospitalized COVID-19 patients who also had heart disease or risk factors like diabetes or high blood pressure. The goal was to see if the drug could lower the chance of death, needing intensive care, or having heart problems. The t…
Matched conditions: CARDIOVASCULAR DISEASES
Phase: PHASE2, PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Aspirin study for kidney patients halted early – did the risks outweigh the benefits?
Disease control TerminatedThis study looked at whether taking a daily low-dose aspirin could help people with chronic kidney disease avoid their first heart attack or stroke. Over 4,600 participants were randomly assigned to take aspirin or receive usual care. The trial was stopped early, and the final re…
Matched conditions: CARDIOVASCULAR DISEASES
Phase: PHASE3 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can checking blood pressure at home help kidney transplant patients?
Disease control TerminatedThis study tested whether kidney transplant recipients with high blood pressure could better control their condition by monitoring their blood pressure at home, compared to standard clinic visits. The trial planned to enroll many participants but was stopped early after only 21 p…
Matched conditions: CARDIOVASCULAR DISEASES
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Skin test could warn of hidden blood vessel trouble
Knowledge-focused TerminatedThis study looked at how tiny blood vessels in the skin of healthy volunteers respond to substances that make them widen or narrow. Researchers used a mild electrical current to deliver these substances through the skin and measured changes in blood flow with light. The goal was …
Matched conditions: CARDIOVASCULAR DISEASES
Phase: NA • Sponsor: University Hospital, Linkoeping • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Painkiller showdown: which is safer for the heart?
Knowledge-focused TerminatedThis study looked at how two common pain relievers—celecoxib (a Coxib) and naproxen (an NSAID)—affect blood clotting in people with rheumatoid arthritis who also have heart disease or are at high risk for it. All participants took low-dose aspirin daily. The goal was to see if on…
Matched conditions: CARDIOVASCULAR DISEASES
Phase: PHASE4 • Sponsor: Platelet and Thrombosis Research, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Heart device study in india aims to track AF progression
Knowledge-focused TerminatedThis study looked at how Medtronic heart devices detect and manage atrial fibrillation (AF) in Indian patients. It tracked whether the condition became persistent over time. The study enrolled 79 people over 55 with heart devices. It was terminated early, so results are limited.
Matched conditions: CARDIOVASCULAR DISEASES
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Heart surgery warning: thin vessel layer may predict deadly complications
Knowledge-focused TerminatedThis study aimed to see if measuring the glycocalyx—a thin, protective layer inside blood vessels—before heart surgery could predict serious problems like shock, kidney failure, or death. Researchers planned to include 130 adults having heart surgery with a heart-lung machine. Th…
Matched conditions: CARDIOVASCULAR DISEASES
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC